The FDA is working with manufacturers of isoxazoline products to include new label information
The FDA is working with manufacturers of isoxazoline products to include new label information

SAFETY ALERT: Pet owners warned of side-effects

The U.S. Food and Drug Administration has issued a warning to pet owners and veterinarians about the potential for neurologic adverse reactions to flea and tick treatments for dogs and cats.

The FDA state that some animals receiving drugs in the isoxazoline class, including Bravecto, Nexgard, Credelio and Simparica have experienced adverse events including muscle tremors, ataxia, and seizures.

While these medications are still considered to be safe to use, with the majority of pet owners finding no adverse reactions in their pets, the FDA is working with manufacturers of isoxazoline products to include new label information which highlights these possible neurologic events, thus making a more informed decision for their pets.

Why now?

According to the release, although FDA scientists carefully evaluate an animal drug prior to approval, there is the potential for new information to emerge after marketing, when the product is used in a much larger population.

In the first three years after approval, the FDA pays particularly close attention to adverse event reports, looking for any safety information that may emerge.



Juveniles charged after weekend car theft crime spree

premium_icon Juveniles charged after weekend car theft crime spree

The events ended in a serious crash, rear-ending a taxi

'Nothing left to salvage': Kabra couple loses everything

premium_icon 'Nothing left to salvage': Kabra couple loses everything

They had minutes to flee an inferno in catastrophic conditions

'The boat had been painted silver and it was still wet'

premium_icon 'The boat had been painted silver and it was still wet'

Woman busted for selling stolen boat on Facebook

Local Partners